Impact of treatment on the outcome of acute myeloid leukemia with inversion 16: A single institution's experience

Leukemia

Volumn 15, Issue 9, 2001, Pages 1326-1330

  Razzouk, B I ^a   Raimondi, S C ^a   Srivastava, D K ^a   Pritchard, M ^a   Behm, F G ^a   Tong, X ^a   Sandlund, J T ^a   Rubnitz, J E ^a   Pui, C H ^a   Ribeiro, R C ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

2 chlorodeoxyadenosine; Acute myeloid leukemia; Children; Cytarabine; Etoposide; Inversion 16

Indexed keywords

AMSACRINE; AZACITIDINE; CLADRIBINE; CYTARABINE; DAUNORUBICIN; ETOPOSIDE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER RECURRENCE; CANCER SURVIVAL; CAUSE OF DEATH; CHILD; CHROMOSOME 16P; CHROMOSOME INVERSION; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL PROTOCOL; COMORBIDITY; CONTROLLED STUDY; CYTOGENETICS; DOSE RESPONSE; EXPERIENCE; FEMALE; HUMAN; INFANT; LEUKEMIA REMISSION; MALE; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

EID: 17944374707     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402215     Document Type: Article

References (33)

1. Acute myelomonocytic leukemia with abnormal eosinophils and inv(16) or t (16;16) has a favorable prognosis
2. Prognostic significance of chromosomal abnormalities in acute nonlymphocytic leukemia: A study of 343 patients
3. Cytogenetic pattern in acute myelogenous leukemia: A major reproducible determinant of outcome
4. Specific chromosomal abnormalities in acute nonlymphocytic leukemia correlate with drug susceptibility in vivo
5. Correlation of chromosome abnormalities with patient characteristics, histologic subtype, and induction success in children with acute nonlymphocytic leukemia
6. Clinical and prognostic significance of chromosomal abnormalities in childhood acute myeloid leukemia de novo
7. The importance of diagnostic cytogenetics on outcome in AML: Analysis of 1612 patients entered into the MRC AML 10 trial
8. Definition of a standard-risk group in children with AML
9. Chromosomal abnormalities in 478 children with acute myeloid leukemia: Clinical characteristics and treatment outcome in a Cooperative Pediatric Oncology Group study-POG 8821
10. Prognostic importance of cytogenetic subgroups in de novo pediatric acute nonlymphocytic leukemia
11. Allogeneic bone marrow transplantation in a program of intensive sequential chemotherapy for children and young adults with acute nonlymphocytic leukemia in first remission
12. Early intensification of chemotherapy for childhood acute nonlymphoblastic leukemia: Improved remission induction with a five-drug regimen including etoposide
13. Long-term results following treatment of newly-diagnosed acute myelogenous leukemia with continuous-infusion high-dose cytosine arabinoside
14. Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype
15. Treatment of childhood acute myelogenous leukemia with an intensive regimen (AML-87) that individualizes etoposide and cytarabine dosages: Short- and long-term effects
16. Current strategies for treatment of acute myeloid leukemia at St Jude Children's Research Hospital
17. Cytogenetics as a diagnostic aid for childhood hematological disorders. Conventional cytogenetic techniques, fluorescence in situ hybridization and comparative genomic hybridization
18. An International System for Human Cytogenetic Nomenclature
19. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Part 2. Analysis and examples
20. Identification of an inversion 16 coexisting with an isochromosome 22q by in situ hybridization in a case of childhood AML M4e
21. Underestimation of inversion (16) in acute myeloid leukemia using standard cytogenetics as compared with polymerase chain reaction: Results of a prospective investigation
22. Heterogeneity in CBFβ/MYH11 fusion messages encoded by the inv(16) (p13q22) and the t (16;16)(p13;q22) in acute myelogenous leukemia
23. Identification of the inverted chromosome 16 using chromosome painting
24. Use of dual-color interphase FISH for the detection of inv(16) in acute myeloid leukemia at diagnosis, relapse and during follow-up: A study of 23 patients
25. High concordance of karyotype analysis and RT-PCR for CBFβ/MYH 11 in unselected patients with acute myeloid leukemia
26. 2 expression
27. 2-Chlorodeoxyadenosine produces a high rate of complete hematologic remission in relapsed acute myeloid leukemia
28. Complete hematologic remissions induced by 2-chlorodeoxyadenosine in children with newly diagnosed acute myeloid leukemia
29. Factors associated with hematologic response to 2-chloro-deoxyadenosine (2-CDA) in de novo pediatric acute myeloid leukemia
30. Patients with t (8;21) (q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered
31. Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukaemia: Results of the United Kingdom Medical Research Council's 10th AML trial
32. Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood
33. Cladribine activity in adult Langerhans cell histiocytosis